Lien Desteghe1, Lara Engelhard2, Zina Raymaekers2, Kiki Kluts2, Johan Vijgen3, Dagmara Dilling-Boer3, Pieter Koopman3, Joris Schurmans3, Paul Dendale4, Hein Heidbuchel4. 1. Faculty of Medicine and Life Sciences, Hasselt University, Martelarenlaan 42, 3500 Hasselt, Belgium; Heart Centre Hasselt, Jessa Hospital, Stadsomvaart 11, 3500 Hasselt, Belgium. Electronic address: lien.desteghe@uhasselt.be. 2. Faculty of Medicine and Life Sciences, Hasselt University, Martelarenlaan 42, 3500 Hasselt, Belgium. 3. Heart Centre Hasselt, Jessa Hospital, Stadsomvaart 11, 3500 Hasselt, Belgium. 4. Faculty of Medicine and Life Sciences, Hasselt University, Martelarenlaan 42, 3500 Hasselt, Belgium; Heart Centre Hasselt, Jessa Hospital, Stadsomvaart 11, 3500 Hasselt, Belgium.
Abstract
OBJECTIVE: The aim of this study was to develop and validate a new questionnaire, the Jessa Atrial fibrillation Knowledge Questionnaire (JAKQ), to test the knowledge of patients with atrial fibrillation (AF) about the arrhythmia, its treatment and their ability for self-management. METHODS: The JAKQ was developed based on other questionnaires, two educational checklists and patient information support websites. The JAKQ was validated based on content validity, face validity, response process, discriminatory potential and sensitivity of the questionnaire, construct validity and reliability. It was presented to both outpatients and hospitalised patients. RESULTS: A total of 466 AF patients completed the JAKQ. The final 16-item JAKQ consists of 8 questions about AF in general, 5 questions about oral anticoagulation (OAC) therapy and either 3 questions about vitamin K antagonists (VKA) or non-vitamin K antagonist oral anticoagulants (NOAC). The questionnaire is completed in 6.5±2.4min. The mean score on the JAKQ is 55.8±18.6% with a wide discriminatory span of scores. The JAKQ reveals important knowledge gaps, like 28.8% of the patients not being aware of their medical condition named 'atrial fibrillation', 33.7% being unaware that AF can cause thromboembolism and stroke, and 78.6% of the patients taking VKA and 57.0% of the patients on NOACs not knowing what to do when missing an OAC dose. CONCLUSIONS: The JAKQ is a brief, complete and valid AF-specific knowledge questionnaire that can be used in daily practice to assess patients' insight into their condition. It could be used as a tool for individually tailored patient education.
OBJECTIVE: The aim of this study was to develop and validate a new questionnaire, the Jessa Atrial fibrillation Knowledge Questionnaire (JAKQ), to test the knowledge of patients with atrial fibrillation (AF) about the arrhythmia, its treatment and their ability for self-management. METHODS: The JAKQ was developed based on other questionnaires, two educational checklists and patient information support websites. The JAKQ was validated based on content validity, face validity, response process, discriminatory potential and sensitivity of the questionnaire, construct validity and reliability. It was presented to both outpatients and hospitalised patients. RESULTS: A total of 466 AFpatients completed the JAKQ. The final 16-item JAKQ consists of 8 questions about AF in general, 5 questions about oral anticoagulation (OAC) therapy and either 3 questions about vitamin K antagonists (VKA) or non-vitamin K antagonist oral anticoagulants (NOAC). The questionnaire is completed in 6.5±2.4min. The mean score on the JAKQ is 55.8±18.6% with a wide discriminatory span of scores. The JAKQ reveals important knowledge gaps, like 28.8% of the patients not being aware of their medical condition named 'atrial fibrillation', 33.7% being unaware that AF can cause thromboembolism and stroke, and 78.6% of the patients taking VKA and 57.0% of the patients on NOACs not knowing what to do when missing an OAC dose. CONCLUSIONS: The JAKQ is a brief, complete and valid AF-specific knowledge questionnaire that can be used in daily practice to assess patients' insight into their condition. It could be used as a tool for individually tailored patient education.
Authors: Anna R LaRosa; Alexandra M Pusateri; Andrew D Althouse; Abigail S Mathier; Utibe R Essien; Jared W Magnani Journal: Int J Cardiol Date: 2019-06-20 Impact factor: 4.164
Authors: Brystana G Kaufman; Sunghee Kim; Karen Pieper; Larry A Allen; Bernard J Gersh; Gerald V Naccarelli; Michael D Ezekowitz; Gregg C Fonarow; Kenneth W Mahaffey; Daniel E Singer; Paul S Chan; James V Freeman; Jack Ansell; Peter R Kowey; James A Rieffel; Jonathan Piccini; Eric Peterson; Emily C O'Brien Journal: Heart Date: 2017-08-08 Impact factor: 5.994
Authors: Tammy R Toscos; Amanda Coupe; Shauna Wagner; Michelle Drouin; Amelia E Roebuck; Carly N Daley; Maria D Carpenter; Michael J Mirro Journal: Nurs Open Date: 2020-05-12
Authors: Mossab Aljuaid; Qussay Marashly; Jad AlDanaf; Ibrahim Tawhari; Michel Barakat; Rody Barakat; Brittany Zobell; William Cho; Mihail G Chelu; Nassir F Marrouche Journal: Clin Med Insights Cardiol Date: 2020-01-20
Authors: Colleen Sedney; Hawa O Abu; Katherine Trymbulak; Jordy Mehawej; Ziyue Wang; Molly E Waring; Jane Saczynski; David D McManus Journal: Patient Educ Couns Date: 2020-07-15